November 2006
Mayo Clinic Proceedings;Nov2006, Vol. 81 Issue 11, p1509
Academic Journal
Correction notice
Two corrections to the articles "Monoclonal Gammopathy of Undetermined Significance, Waldenström Macroglobulinemia, AL Amyloidosis, and Related Plasma Cell Disorders: Diagnosis and Treatment," that was published in the May 2006 issue and "Oncologic Emergencies: Diagnosis and Treatment," that was published in the June 2006 issue are presented.


Related Articles

  • Monoclonal Gammopathy of Undetermined Significance, Waldenström Macroglobulinemia, AL Amyloidosis, and Related Plasma Cell Disorders: Diagnosis and Treatment. Rajkumar, S. Vincent; Dispenzieri, Angela; Kyle, Robert A. // Mayo Clinic Proceedings;May2006, Vol. 81 Issue 5, p693 

    The spectrum of plasma cell disorders Is broad. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma are asymptomatic disorders characterized by monoclonal plasma cell proliferation in the bone marrow in the absence of end-organ damage. Waldenström...

  • MGUS preceded nearly all multiple myelomas.  // Hem/Onc Today;7/10/2009, Vol. 10 Issue 13, p30 

    The article deals with two studies which found that premalignant plasma cell disorder monoclonal gammopathy of undetermined significant almost always preceded the development of multiple myeloma.

  • Progression Risk for Smoldering Myeloma. Artz, Andrew // Clinical Oncology Alert;Aug2007, Vol. 23 Issue 8, p59 

    MONOCLONAL GAMMOPATHIES ENCOMPASS A spectrum of disorders related to a clonal proliferation of plasma cells. Although not necessarily distinct entities, diagnostic criteria separate monoclonal gammopathy of unknown significance, smoldering multiple myeloma, and multiple myeloma. To diagnose...

  • Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma. Woitge, H W; Pecherstorfer, M; Horn, E; Keck, A-V; Diel, I J; Bayer, P; Ludwig, H; Ziegler, R; Seibel, M J // British Journal of Cancer;2/1/2001, Vol. 84 Issue 3, p344 

    To test the potential of immunoreactive BSP, a non-collagenous bone matrix component, as a clinical guide in patients with plasma cell dyscrasias, serum BSP concentrations were measured in 62 patients with newly diagnosed multiple myeloma (MM) followed over a period of 4 years, in 46 patients...

  • Prevalence and type of monoclonal gammopathy of undetermined significance in an apparently healthy Nigerian population: a cross sectional study. Onwah, A. Lawretta; Adeyemo, Titilope A.; Adediran, Adewumi; Ajibola, Sarah O.; Akanmu, Alani S. // BMC Blood Disorders;2012, Vol. 12 Issue 1, p7 

    Background: The prevalence of monoclonal gammopathy of undetermined significance (MGUS), a premalignant plasma-cell disorder has not been determined in our geographic area Nigeria. Methods: A cross sectional survey was carried on apparently healthy Nigerians selected by multistage sampling...

  • Paraprotein management. Smellie, W. Stuart A.; Spickett, Gavin P. // BMJ: British Medical Journal (International Edition);7/22/2006, Vol. 333 Issue 7560, p185 

    We present two cases illustrating the use of electrophoresis in the diagnosis and monitoring of plasma cell dyscrasias. The presence of monoclonal protein bands (paraproteins) in myeloma is well recognised; other conditions in which paraproteins may be seen are less well understood, as is the...

  • Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes: the POEMS syndrome. Solomons, Richard E. B. // Journal of the Royal Society of Medicine;Jul1982, Vol. 75 Issue 7, p553 

    The article presents a case study on a Caucasian man having plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome. In this report, the author examines the features manifested by the patient, which occur together in a number of...

  • Elimination of the Need for Urine Studies in the Screening Algorithm for Monoclonal Gammopathies by Using Serum Immunofixation and Free Light Chain Assays. Katzmann, Jerry A.; Dispenzieri, Angela; Kyle, Robert A.; Snyder, Melissa R.; Plevak, Matthew F.; Larson, Dirk R.; Abraham, Roshini S.; Lust, John A.; Melton III, L. Joseph; Rajkumar, S. Vincent // Mayo Clinic Proceedings;Dec2006, Vol. 81 Issue 12, p1575 

    OBJECTIVE: To determine the relative diagnostic contribution of urine assays as part of the screening algorithm for monoclonal gammopathies. PATIENTS AND METHODS: We Identified 428 patients with a monoclonal gammopathy and monoclonal urinary protein at initial diagnosis of plasma cell dyscrasia...

  • Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome. Wang, Chen; Su, Wei; Zhang, Wei; Di, Qian; Duan, Ming-Hui; Ji, Wei; Cao, Xin-Xin; Zhou, Dao-Bin; Li, Jian // Annals of Hematology;Jul2014, Vol. 93 Issue 7, p1201 

    POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome is a rare plasma cell dyscrasia. Nearly all patients present with a λ-restricted monoclonal gammopathy. Most patients with POEMS syndrome have been reported to have a normal serum free light...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics